Congress Asset Management Co. Buys 82,838 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Congress Asset Management Co. grew its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 9.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 991,580 shares of the company's stock after buying an additional 82,838 shares during the quarter. Congress Asset Management Co. owned 2.00% of Prestige Consumer Healthcare worth $85,246,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently made changes to their positions in PBH. Franklin Resources Inc. grew its position in Prestige Consumer Healthcare by 0.7% in the 4th quarter. Franklin Resources Inc. now owns 21,735 shares of the company's stock worth $1,697,000 after purchasing an additional 150 shares during the period. CIBC Private Wealth Group LLC grew its position in Prestige Consumer Healthcare by 48.9% in the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock worth $34,000 after purchasing an additional 152 shares during the period. McIlrath & Eck LLC boosted its stake in shares of Prestige Consumer Healthcare by 19.1% during the 4th quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock worth $75,000 after acquiring an additional 154 shares during the last quarter. QRG Capital Management Inc. boosted its stake in shares of Prestige Consumer Healthcare by 3.3% during the 4th quarter. QRG Capital Management Inc. now owns 5,496 shares of the company's stock worth $429,000 after acquiring an additional 176 shares during the last quarter. Finally, O Shaughnessy Asset Management LLC boosted its stake in shares of Prestige Consumer Healthcare by 3.0% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 7,026 shares of the company's stock worth $549,000 after acquiring an additional 207 shares during the last quarter. Hedge funds and other institutional investors own 99.95% of the company's stock.

Insiders Place Their Bets

In other news, SVP Mary Beth Fritz sold 1,678 shares of the business's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $90.00, for a total value of $151,020.00. Following the sale, the senior vice president now directly owns 17,157 shares in the company, valued at $1,544,130. The trade was a 8.91% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 1.60% of the company's stock.

Prestige Consumer Healthcare Price Performance

PBH stock traded up $0.49 during mid-day trading on Friday, hitting $85.11. The company had a trading volume of 189,224 shares, compared to its average volume of 299,912. The company has a market capitalization of $4.21 billion, a price-to-earnings ratio of 19.93, a P/E/G ratio of 2.69 and a beta of 0.45. Prestige Consumer Healthcare Inc. has a 12-month low of $63.79 and a 12-month high of $90.04. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. The company has a 50-day moving average price of $83.53 and a 200 day moving average price of $82.52.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.30 by $0.02. The business had revenue of $296.52 million for the quarter, compared to analysts' expectations of $289.36 million. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. The business's quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.02 EPS. On average, research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. Wall Street Zen upgraded shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, May 17th. Royal Bank of Canada upgraded shares of Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Finally, Oppenheimer lifted their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a research note on Thursday, February 13th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat, Prestige Consumer Healthcare has a consensus rating of "Moderate Buy" and an average target price of $93.33.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.